%20(1).svg)
Insights from a Principal Engineer
Adaptable Formulation Development Strategies for Today with a Focus on Tomorrow
Wesley Tatum, PhD (Principal Engineer, Process & Product Development, Serán Bioscience) shares insights surrounding formulation and process development that focus on the future of the industry.
At the 2023 American Association of Pharmaceutical Scientists (AAPS) conference, Pharmaceutical Technology spoke with Serán's Wesley Tatum, PhD, about formulation strategies that consider the future of the industry.
Learn more about:
- Leveraging expertise in material science and particle engineering, Serán addresses the industry’s most challenging problem statements in drug development
- A partnership philosophy that emphasizes creativity and collaboration enables rapid development of advanceable formulations and processes with minimal material
- Identifying the best strategy and formulation technology for each program’s unique considerations and needs
About Serán
Serán BioScience, LLC, is a science-driven Drug Development Partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, visit www.Seranbio.com or email us at hello@seranbio.com.
Contact
Serán BioScience, LLC
63047 Layton Ave, Bend, OR 97701 USA
www.seranbio.com
.svg)